{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:59:49Z","timestamp":1778626789548,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,4,7]],"date-time":"2016-04-07T00:00:00Z","timestamp":1459987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"},{"start":{"date-parts":[[2016,4,7]],"date-time":"2016-04-07T00:00:00Z","timestamp":1459987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Microgravity"],"DOI":"10.1038\/npjmgrav.2016.13","type":"journal-article","created":{"date-parts":[[2016,4,6]],"date-time":"2016-04-06T17:49:41Z","timestamp":1459964981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Protection against neurodegenerative disease on Earth and in space"],"prefix":"10.1038","volume":"2","author":[{"given":"Yoshiki","family":"Takamatsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wakako","family":"Koike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takato","family":"Takenouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuei","family":"Sugama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianshe","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Waragai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Sekiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,7]]},"reference":[{"key":"BFnpjmgrav201613_CR1","volume-title":"G-Connection: Harness Gravity and Reverse Aging","author":"J Vernikos","year":"2004","unstructured":"Vernikos, J . G-Connection: Harness Gravity and Reverse Aging (iUniverse, Inc.: Lincoln, NE, USA, 2004)."},{"key":"BFnpjmgrav201613_CR2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0273-1177(94)90425-1","volume":"14","author":"FW Booth","year":"1994","unstructured":"Booth, F. W. Terrestrial applications of bone and muscle research in microgravity. Adv. Space Res. 14, 373\u2013376 (1994).","journal-title":"Adv. Space Res."},{"key":"BFnpjmgrav201613_CR3","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/35059243","volume":"409","author":"RJ White","year":"2001","unstructured":"White, R. J. & Averner, M. Humans in space. Nature 409, 1115\u20131118 (2001).","journal-title":"Nature"},{"key":"BFnpjmgrav201613_CR4","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1021\/pr050274r","volume":"5","author":"P Sarkar","year":"2006","unstructured":"Sarkar, P. et al. Proteomic analysis of mice hippocampus in simulated microgravity environment. J. Proteome Res. 5, 548\u2013553 (2006).","journal-title":"J. Proteome Res."},{"key":"BFnpjmgrav201613_CR5","doi-asserted-by":"publisher","first-page":"e53275","DOI":"10.1371\/journal.pone.0053275","volume":"7","author":"JD Cherry","year":"2012","unstructured":"Cherry, J. D. et al. Galactic cosmic radiation leads to cognitive impairment and increased abeta plaque accumulation in a mouse model of Alzheimer's disease. PLoS ONE 7, e53275 (2012).","journal-title":"PLoS ONE"},{"key":"BFnpjmgrav201613_CR6","first-page":"155","volume":"7","author":"M Hashimoto","year":"2012","unstructured":"Hashimoto, M. & La Spada, A. R. Review \u03b2-synuclein in the pathogenesis of Parkinson's disease and related \u03b1-synucleinopathies: emerging roles and new directions Future. Neurology 7, 155\u2013163 (2012).","journal-title":"Neurology"},{"key":"BFnpjmgrav201613_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0896-6273(01)00462-7","volume":"32","author":"M Hashimoto","year":"2001","unstructured":"Hashimoto, M., Rockenstein, E., Mante, M., Mallory, M. & Masliah, E. beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor. Neuron 32, 213\u2013223 (2001).","journal-title":"Neuron"},{"key":"BFnpjmgrav201613_CR8","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1038\/sj.gt.3302349","volume":"11","author":"M Hashimoto","year":"2004","unstructured":"Hashimoto, M. et al. An antiaggregation gene therapy strategy for Lewy body disease utilizing beta-synuclein lentivirus in a transgenic model. Gene Ther. 11, 1713\u20131723 (2004).","journal-title":"Gene Ther."},{"key":"BFnpjmgrav201613_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0006-8993(01)02772-X","volume":"914","author":"E Rockenstein","year":"2001","unstructured":"Rockenstein, E. et al. Altered expression of the synuclein family mRNA in Lewy body and Alzheimer's disease. Brain Res. 914, 48\u201356 (2001).","journal-title":"Brain Res."},{"key":"BFnpjmgrav201613_CR10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1358\/dnp.2007.20.6.1138160","volume":"20","author":"B Gong","year":"2007","unstructured":"Gong, B. & Leznik, E. The role of ubiquitin C-terminal hydrolase L1 in neurodegenerative disorders. Drug News Perspect. 20, 365\u2013370 (2007).","journal-title":"Drug News Perspect."},{"key":"BFnpjmgrav201613_CR11","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/26652","volume":"395","author":"E Leroy","year":"1998","unstructured":"Leroy, E. et al. The ubiquitin pathway in Parkinson's disease. Nature 395, 451\u2013452 (1998).","journal-title":"Nature"},{"key":"BFnpjmgrav201613_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/12647","volume":"23","author":"K Saigoh","year":"1999","unstructured":"Saigoh, K. et al. Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat Genet. 23, 47\u201351 (1999).","journal-title":"Nat Genet."},{"key":"BFnpjmgrav201613_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2004.05.023","volume":"1019","author":"YL Wang","year":"2004","unstructured":"Wang, Y. L. et al. Accumulation of beta- and gamma-synucleins in the ubiquitin carboxyl-terminal hydrolase L1-deficient gad mouse. Brain Res. 1019, 1\u20139 (2004).","journal-title":"Brain Res."},{"key":"BFnpjmgrav201613_CR14","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.molcel.2011.10.015","volume":"44","author":"T Hitosugi","year":"2011","unstructured":"Hitosugi, T. et al. Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism. Mol. Cell 44, 864\u2013877 (2011).","journal-title":"Mol. Cell"},{"key":"BFnpjmgrav201613_CR15","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrn2194","volume":"8","author":"C Ballatore","year":"2007","unstructured":"Ballatore, C., Lee, V. M. & Trojanowski, J. Q. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat. Rev. Neurosci. 8, 663\u2013672 (2007).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFnpjmgrav201613_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3233\/JAD-142646","volume":"47","author":"K Nakamagoe","year":"2015","unstructured":"Nakamagoe, K. et al. Vestibular function impairment in Alzheimer's disease. J. Alzheimers Dis. 47, 185\u2013196 (2015).","journal-title":"J. Alzheimers Dis."},{"key":"BFnpjmgrav201613_CR17","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1002\/jbmr.1940","volume":"28","author":"G Vignaux","year":"2013","unstructured":"Vignaux, G. et al. Bone remodeling is regulated by inner ear vestibular signals. J. Bone Miner. Res. 28, 2136\u20132144 (2013).","journal-title":"J. Bone Miner. Res."},{"key":"BFnpjmgrav201613_CR18","unstructured":"Lenggenhager B., Lopez C . in Open MIND, Vol. 23(T) (eds Metzinger T. & Windt J. M.) (Frankfurt am Main: MIND Group, 2015)."},{"key":"BFnpjmgrav201613_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/VES-2005-15101","volume":"15","author":"PF Smith","year":"2005","unstructured":"Smith P. F., Zheng Y., Horii A., Darlington C. L. Does vestibular damage cause cognitive dysfunction in humans? J. Vestib. Res. 2005; 15: 1\u20139.","journal-title":"J. Vestib. Res."},{"key":"BFnpjmgrav201613_CR20","doi-asserted-by":"publisher","first-page":"e93298","DOI":"10.1371\/journal.pone.0093298","volume":"9","author":"M Basner","year":"2014","unstructured":"Basner, M. et al. Psychological and behavioral changes during confinement in a 520-day simulated interplanetary mission to mars. PLoS ONE 9, e93298 (2014).","journal-title":"PLoS ONE"},{"key":"BFnpjmgrav201613_CR21","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jalz.2015.05.007","volume":"11","author":"MW Weiner","year":"2015","unstructured":"Weiner, M. W. & Veitch, D. P. Introduction to special issue: overview of Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement. 11, 730\u2013733 (2015).","journal-title":"Alzheimers Dement."},{"key":"BFnpjmgrav201613_CR22","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/nrneurol.2015.126","volume":"11","author":"AF Leentjens","year":"2015","unstructured":"Leentjens, A. F. Parkinson disease: depression-risk factor or early symptom in Parkinson disease? Nat. Rev. Neurol. 11, 432\u2013433 (2015).","journal-title":"Nat. Rev. Neurol."},{"key":"BFnpjmgrav201613_CR23","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrneurol.2014.206","volume":"10","author":"A Videnovic","year":"2014","unstructured":"Videnovic, A., Lazar, A. S., Barker, R. A. & Overeem, S. 'The clocks that time us'--circadian rhythms in neurodegenerative disorders. Nat. Rev. Neurol. 10, 683\u2013693 (2014).","journal-title":"Nat. Rev. Neurol."},{"key":"BFnpjmgrav201613_CR24","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1126\/science.1180962","volume":"326","author":"JE Kang","year":"2009","unstructured":"Kang, J. E. et al. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science 326, 1005\u20131007 (2009).","journal-title":"Science"},{"key":"BFnpjmgrav201613_CR25","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1113\/jphysiol.2001.012574","volume":"538","author":"JF Cox","year":"2002","unstructured":"Cox, J. F. et al. Influence of microgravity on astronauts' sympathetic and vagal responses to Valsalva's manoeuvre. J. Physiol. 538, 309\u2013320 (2002).","journal-title":"J. Physiol."},{"key":"BFnpjmgrav201613_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.parkreldis.2013.11.006","volume":"20","author":"M Pilleri","year":"2014","unstructured":"Pilleri, M. et al. Heart rate circadian profile in the differential diagnosis between Parkinson disease and multiple system atrophy. Parkinsonism Relat. Disord. 20, 217\u2013221 (2014).","journal-title":"Parkinsonism Relat. Disord."},{"key":"BFnpjmgrav201613_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2174\/156720512799015064","volume":"9","author":"H Cai","year":"2012","unstructured":"Cai, H. et al. Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders. Curr. Alzheimer Res. 9, 5\u201317 (2012).","journal-title":"Curr. Alzheimer Res."},{"key":"BFnpjmgrav201613_CR28","doi-asserted-by":"publisher","first-page":"a006239","DOI":"10.1101\/cshperspect.a006239","volume":"2","author":"R Mayeux","year":"2012","unstructured":"Mayeux, R. & Stern, Y. Epidemiology of Alzheimer disease. Cold Spring Harb. Perspect. Med. 2, a006239 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"BFnpjmgrav201613_CR29","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S1474-4422(11)70072-2","volume":"10","author":"DE Barnes","year":"2011","unstructured":"Barnes, D. E. & Yaffe, K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 10, 819\u2013828 (2011).","journal-title":"Lancet Neurol."},{"key":"BFnpjmgrav201613_CR30","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.bbadis.2013.01.008","volume":"1832","author":"AI Duarte","year":"2013","unstructured":"Duarte, A. I. et al. Crosstalk between diabetes and brain: glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration. Biochim. Biophys. Acta 1832, 527\u2013541 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnpjmgrav201613_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1001\/archneurol.2011.233","volume":"69","author":"S Craft","year":"2012","unstructured":"Craft, S. et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch. Neurol. 69, 29\u201338 (2012).","journal-title":"Arch. Neurol."},{"key":"BFnpjmgrav201613_CR32","doi-asserted-by":"publisher","first-page":"871","DOI":"10.2165\/11635890-000000000-00000","volume":"26","author":"C Holscher","year":"2012","unstructured":"Holscher, C. Potential role of glucagon-like peptide-1 (GLP-1) in neuroprotection. CNS Drugs 26, 871\u2013882 (2012).","journal-title":"CNS Drugs"},{"key":"BFnpjmgrav201613_CR33","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1172\/JCI68295","volume":"123","author":"I Aviles-Olmos","year":"2013","unstructured":"Aviles-Olmos, I. et al. Exenatide and the treatment of patients with Parkinson's disease. J. Clin. Invest. 123, 2730\u20132736 (2013).","journal-title":"J. Clin. Invest."},{"key":"BFnpjmgrav201613_CR34","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.cmet.2011.01.012","volume":"13","author":"T Kadowaki","year":"2011","unstructured":"Kadowaki, T. & Yamauchi, T. Adiponectin receptor signaling: a new layer to the current model. Cell Metab. 13, 123\u2013124 (2011).","journal-title":"Cell Metab."},{"key":"BFnpjmgrav201613_CR35","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/acn3.77","volume":"1","author":"K Sekiyama","year":"2014","unstructured":"Sekiyama, K. et al. Disease-Modifying Effect of Adiponectin in Model of alpha-Synucleinopathies. Ann. Clin. Transl. Neurol. 1, 479\u2013489 (2014).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"BFnpjmgrav201613_CR36","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nature01705","volume":"423","author":"T Yamauchi","year":"2003","unstructured":"Yamauchi, T. et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423, 762\u2013769 (2003).","journal-title":"Nature"},{"key":"BFnpjmgrav201613_CR37","doi-asserted-by":"publisher","first-page":"11708","DOI":"10.1038\/srep11708","volume":"5","author":"T Ali","year":"2015","unstructured":"Ali, T., Yoon, G. H., Shah, S. A., Lee, H. Y. & Kim, M. O. Osmotin attenuates amyloid beta-induced memory impairment, tau phosphorylation and neurodegeneration in the mouse hippocampus. Sci. Rep. 5, 11708 (2015).","journal-title":"Sci. Rep."},{"key":"BFnpjmgrav201613_CR38","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nature12656","volume":"503","author":"M Okada-Iwabu","year":"2013","unstructured":"Okada-Iwabu, M. et al. A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity. Nature 503, 493\u2013499 (2013).","journal-title":"Nature"},{"key":"BFnpjmgrav201613_CR39","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1196\/annals.1329.020","volume":"1030","author":"S Morita","year":"2004","unstructured":"Morita, S. et al. Hypergravity stimulates osteoblast phenotype expression: a therapeutic hint for disuse bone atrophy. Ann. N. Y. Acad. Sci. 1030, 158\u2013161 (2004).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"BFnpjmgrav201613_CR40","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.neulet.2008.08.067","volume":"445","author":"H Sang","year":"2008","unstructured":"Sang, H. et al. Preconditioning with +Gz acceleration (head-to-foot inertial load) produces neuroprotection against transient focal cerebral ischemia in rats. Neurosci. Lett. 445, 78\u201382 (2008).","journal-title":"Neurosci. Lett."},{"key":"BFnpjmgrav201613_CR41","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1152\/japplphysiol.00707.2002","volume":"95","author":"DC Holley","year":"2003","unstructured":"Holley, D. C., DeRoshia, C. W., Moran, M. M. & Wade, C. E. Chronic centrifugation (hypergravity) disrupts the circadian system of the rat. J. Appl. Physiol. 95, 1266\u20131278 (2003).","journal-title":"J. Appl. Physiol."}],"container-title":["npj Microgravity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/npjmgrav201613.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/npjmgrav201613","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/npjmgrav201613.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T12:09:35Z","timestamp":1672834175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npjmgrav201613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,7]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,8]]}},"alternative-id":["BFnpjmgrav201613"],"URL":"https:\/\/doi.org\/10.1038\/npjmgrav.2016.13","relation":{},"ISSN":["2373-8065"],"issn-type":[{"value":"2373-8065","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,7]]},"assertion":[{"value":"21 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16013"}}